Arformoterol - Latest Advances

IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?

Journal: Arerugi = [Allergy]

Published: October 13, 2025

Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β2-Adrenoceptor Agonists.

Journal: Biochemistry

Published: August 07, 2025

Sporadic lymphangioleiomyomatosis in young female patient: A case report and review of the literature.

Journal: International journal of surgery case reports

Published: July 26, 2025

Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI.

Journal: Pharmaceutics

Published: July 21, 2025

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

Journal: JAMA internal medicine

Published: July 07, 2025

Impact of smoking on asthma control with extrafine beclomethasone/formoterol: post hoc analysis of a prospective cohort study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: June 27, 2025

Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation.

Journal: Pathogens (Basel, Switzerland)

Published: June 17, 2025

The β2-adrenoceptor agonist formoterol reverses metabolic dysfunction in the diabetic proximal tubule.

Journal: The Journal of pharmacology and experimental therapeutics

Published: June 05, 2025

Formoterol, a Clinically Approved Drug, Inhibits Ferroptosis by Suppressing Lipid Peroxidation and Attenuates APAP-Induced Acute Liver Injury.

Journal: Chemico-biological interactions

Published: June 05, 2025

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.

Journal: Advances in therapy

Published: May 30, 2025

Activation of the β2-adrenoceptor by formoterol induces calcium-dependent exocytosis of synaptic vesicles at the neuromuscular junction in a sex-specific manner.

Journal: Neurochemistry international

Published: May 28, 2025

A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β2-Agonists Used for Asthma and COPD.

Journal: Pharmacology research & perspectives

Published: May 28, 2025

Filters

IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?

IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?

Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β2-Adrenoceptor Agonists.

Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β2-Adrenoceptor Agonists.

Sporadic lymphangioleiomyomatosis in young female patient: A case report and review of the literature.

Sporadic lymphangioleiomyomatosis in young female patient: A case report and review of the literature.

Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI.

Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI.

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

Impact of smoking on asthma control with extrafine beclomethasone/formoterol: post hoc analysis of a prospective cohort study.

Impact of smoking on asthma control with extrafine beclomethasone/formoterol: post hoc analysis of a prospective cohort study.

Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation.

Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation.

The β2-adrenoceptor agonist formoterol reverses metabolic dysfunction in the diabetic proximal tubule.

The β2-adrenoceptor agonist formoterol reverses metabolic dysfunction in the diabetic proximal tubule.

Formoterol, a Clinically Approved Drug, Inhibits Ferroptosis by Suppressing Lipid Peroxidation and Attenuates APAP-Induced Acute Liver Injury.

Formoterol, a Clinically Approved Drug, Inhibits Ferroptosis by Suppressing Lipid Peroxidation and Attenuates APAP-Induced Acute Liver Injury.

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.

Activation of the β2-adrenoceptor by formoterol induces calcium-dependent exocytosis of synaptic vesicles at the neuromuscular junction in a sex-specific manner.

Activation of the β2-adrenoceptor by formoterol induces calcium-dependent exocytosis of synaptic vesicles at the neuromuscular junction in a sex-specific manner.

A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β2-Agonists Used for Asthma and COPD.

A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β2-Agonists Used for Asthma and COPD.